Etanercept attenuates TNFα-mediated kidney injury in a rat model of brain death kidney donation

Brain death (BD) induces a robust inflammatory response that impairs kidney quality before transplantation. Given that TNFα is a central upstream mediator of BD-related injury, we investigated whether selective TNFα inhibition using etanercept could mitigate renal damage in a rat model of BD. BD was maintained for 6 hours in anesthetized rats (n=6 controls; n=12 etanercept-treated; balanced for sex), after which animals were randomized to receive either etanercept (ETNCPT) or vehicle (CTL). We evaluated serum biomarkers, histological kidney injury, immune cell infiltration, and whole-kidney transcriptomic profiles. Etanercept significantly reduced circulating TNFα levels (15.25[12.30-21.05] vs. 34.23[26.03-50.19] pg/mL; p<0.001), while other cytokines remained unchanged. Kidney function parameters (serum creatinine, BUN), electrolytes, and hemodynamics were similar accross groups. In contrast, etanercept markedly attenuated renal injury, reducing acute tubular necrosis (30.0 [15.0-35.0]% vs. 42.5 [40.0-51.3]%; p<0.001), CD11b⁺ myeloid infiltration (0.13 [0.11-0.15]% vs. 0.21 [0.19-0.27]%; p<0.001), tubular KIM-1 expression (0.04 [0.01-0.08]% vs. 0.17 [0.13-0.18]%; p<0.001), and apoptosis (-69%; p=0.036). Transcriptomic analysis identified 281 differentially expressed genes after TNFα blockade, with strong inhibition of inflammatory and apoptotic pathways including TNF signaling, TNFR1/TNFR2 activation, death receptor signaling, and cytokine storm signaling. Predicted downstream effects included reduced kidney cell death and inflammation. Sex-stratified analyses showed similar directional effects in males and females. In summary, early TNFα blockade after BD selectively neutralizes TNFα, limits immune recruitment, and suppresses injury and inflammatory signaling at cellular and transcriptomic levels. Targeting TNFα during kidney donor management may offer a promising strategy to improve kidney quality before transplantation.

Authors

Institutions

Publication Details

Journal
American Journal of Physiology-Renal Physiology
Published
2026-06-27
DOI
https://doi.org/10.1152/ajprenal.00001.2026
Primary Topic
Organ Donation and Transplantation
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Etanercept attenuates TNFα-mediated kidney injury in a rat model of brain death kidney donation

Tiago Pinto Coelho, Olivier Detry, Margaux Navez, François Jouret et al.
American Journal of Physiology-Renal Physiology
Organ Donation and Transplantation
article

Etanercept attenuates TNFα-mediated kidney injury in a rat model of brain death kidney donation

Tiago Pinto Coelho, Olivier Detry, Margaux Navez, François Jouret, J Abdelmalki, M Vandermeulen, P Erpicum
article en

Abstract

Brain death (BD) induces a robust inflammatory response that impairs kidney quality before transplantation. Given that TNFα is a central upstream mediator of BD-related injury, we investigated whether selective TNFα inhibition using etanercept could mitigate renal damage in a rat model of BD. BD was maintained for 6 hours in anesthetized rats (n=6 controls; n=12 etanercept-treated; balanced for sex), after which animals were randomized to receive either etanercept (ETNCPT) or vehicle (CTL). We evaluated serum biomarkers, histological kidney injury, immune cell infiltration, and whole-kidney transcriptomic profiles. Etanercept significantly reduced circulating TNFα levels (15.25[12.30-21.05] vs. 34.23[26.03-50.19] pg/mL; p<0.001), while other cytokines remained unchanged. Kidney function parameters (serum creatinine, BUN), electrolytes, and hemodynamics were similar accross groups. In contrast, etanercept markedly attenuated renal injury, reducing acute tubular necrosis (30.0 [15.0-35.0]% vs. 42.5 [40.0-51.3]%; p<0.001), CD11b⁺ myeloid infiltration (0.13 [0.11-0.15]% vs. 0.21 [0.19-0.27]%; p<0.001), tubular KIM-1 expression (0.04 [0.01-0.08]% vs. 0.17 [0.13-0.18]%; p<0.001), and apoptosis (-69%; p=0.036). Transcriptomic analysis identified 281 differentially expressed genes after TNFα blockade, with strong inhibition of inflammatory and apoptotic pathways including TNF signaling, TNFR1/TNFR2 activation, death receptor signaling, and cytokine storm signaling. Predicted downstream effects included reduced kidney cell death and inflammation. Sex-stratified analyses showed similar directional effects in males and females. In summary, early TNFα blockade after BD selectively neutralizes TNFα, limits immune recruitment, and suppresses injury and inflammatory signaling at cellular and transcriptomic levels. Targeting TNFα during kidney donor management may offer a promising strategy to improve kidney quality before transplantation.

American Journal of Physiology-Renal Physiology
University of Liège (BE), Centre Hospitalier Universitaire de Liège (BE)
Fonds De La Recherche Scientifique - FNRS, Fonds pour la Formation à la Recherche dans l’Industrie et dans l’Agriculture
Good health and well-being
Openalex Percentile: Top 6%
Organ Donation and Transplantation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.